Immunome IMNM
NASDAQ IMNM
$21.89 +0.21 (+0.97%)
At close: Sep 29, 2026 · 4:00 PM EDT

Immunome (IMNM) Operating Expenses (2019 - 2026)

Updated

Immunome (IMNM) recorded Operating Expenses of $78.14 million in Q2 2026, up 54.7% from $50.49 million a year earlier and up 31.7% from the prior quarter.

Analysis

Immunome (IMNM) Operating Expenses (2019 - 2026) Analysis & Trends

On a TTM basis, Immunome's Operating Expenses came in at $270.47 million as of Jun 30, 2026, up 14.0% year-over-year; for FY2025, it came in at $231.05 million, down 26.6% from FY2024.

  • Annual Operating Expenses has a five-year compound annual growth rate of 79.9% (FY2020 to FY2025).
  • Across earlier years, Operating Expenses came in at $314.84 million in FY2024 (+154.8%), $123.55 million in FY2023 (+234.8%), $36.9 million in FY2022 (+46.4%) and $25.2 million in FY2021 (+105.6%).
  • The Q2 2026 figure is the highest quarterly Operating Expenses since Q4 2024.
  • On a year-over-year basis, Operating Expenses rose in five of the last eight quarters, with growth averaging 71.3%.
  • Peak year-over-year performance for Operating Expenses in the last five years was growth of 551.8% in Q3 2024, against a decline of 64.3% in Q1 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $59.33 million (Q1 2026), $72.86 million (Q4 2025) and $60.14 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Immunome 2.46 Bn 429.67 Mn - 78.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 78.14 Mn
Mar 31, 2026 59.33 Mn
Dec 31, 2025 72.86 Mn
Sep 30, 2025 60.14 Mn
Jun 30, 2025 50.49 Mn
Mar 31, 2025 47.56 Mn
Dec 31, 2024 85.71 Mn
Sep 30, 2024 53.43 Mn
Jun 30, 2024 42.37 Mn
Mar 31, 2024 133.33 Mn
Dec 31, 2023 98.48 Mn
Sep 30, 2023 8.20 Mn
Jun 30, 2023 10.04 Mn
Mar 31, 2023 6.84 Mn
Dec 31, 2022 7.79 Mn
Sep 30, 2022 8.53 Mn
Jun 30, 2022 8.93 Mn
Mar 31, 2022 11.65 Mn
Dec 31, 2021 7.84 Mn
Sep 30, 2021 7.72 Mn
API Access

Immunome Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=IMNM&period=max&api_key=YOUR_API_KEY